JL

Jianyu LU

LC Luoxin Pharmaceutical (Shanghai) Co.: 4 patents #3 of 19Top 20%
SC Shandong Luoxin Pharmaceutical Group Stock Co.: 3 patents #3 of 29Top 15%
G( Genfleet Therapeutics (Shanghai): 2 patents #1 of 19Top 6%
MD Medshine Discovery: 2 patents #33 of 162Top 25%
CC Chia Tai Tianqing Pharmaceutical Group Co.: 1 patents #163 of 370Top 45%
Overall (All Time): #596,450 of 4,157,543Top 15%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
12221432 Estrogen receptor antagonist Shuwen DUAN, Lihong Hu, Charles Z. Ding, Guoping HU, Jian Li +1 more 2025-02-11
12098127 Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method therefor Huijun HE, Shenyi Shi, Charles Z. Ding, Lihong Hu, Bin Shi +3 more 2024-09-24
11691974 3,9-diazaspiro[5,5]undecane compound as FLT3 and AXL inhibitors Xiangyu FU, Charles Z. Ding, Lihong Hu, Wen Jiang, Jian Li +1 more 2023-07-04
11236112 Crystal form and salt form of TGF-βRI inhibitor and preparation method therefor Lifang Wu, Huijun HE, Charles Z. Ding, Lihong Hu, Weidong Li +3 more 2022-02-01
11034653 Crystal form of estrogen receptor inhibitor and preparation method therefor Huijun HE, Weidong Li, Shenyi Shi, Zhijuan Chen, Charles Z. Ding +3 more 2021-06-15
10774081 Indolo substituted piperidine compound as estrogen receptor down-regulator Charles Z. Ding, Xu ZENG, Huijun HE, Shuhui CHEN, Lihong Hu +2 more 2020-09-15
10548883 Benzotriazole-derived α and β-unsaturated amide compound used as TGF-β RI inhibitor Fei Sun, Lifang Wu, Charles Z. Ding, Guoping HU, Jian Li +1 more 2020-02-04
10519143 Substituted-indole-compounds as estrogen receptor down-regulators Charles Z. Ding, Lihong Hu, Huijun HE, Shuhui CHEN, Jiaqiang Dong +1 more 2019-12-31